Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 5
Submit an article Journal homepage
639
Views
10
CrossRef citations to date
0
Altmetric
Review

Current pharmacotherapy for tic disorders

Nicholas Cothrosa Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Calgary, Alberta, CanadaView further author information
,
Alex Medinaa Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Calgary, Alberta, CanadaView further author information
&
Tamara Pringsheima Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Calgary, Alberta, Canada;b Department of Psychiatry, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, Alberta, Canada;c Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaCorrespondence[email protected]
View further author information
Pages 567-580 | Received 20 Aug 2019, Accepted 22 Jan 2020, Published online: 14 Apr 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andrea E. Cavanna. (2022) Current and emerging pharmacotherapeutic strategies for Tourette syndrome. Expert Opinion on Pharmacotherapy 23:13, pages 1523-1533.
Read now

Articles from other publishers (9)

Hao Gong, Xiangyu Du, Anping Su & Yaowu Du. (2023) Pharmacological treatment of Tourette’s syndrome: from the past to the future. Neurological Sciences.
Crossref
Luis C Farhat, Emily Behling, Angeli Landeros-Weisenberger, Jessica L S Levine, Pedro Macul Ferreira de Barros, Ziyu Wang & Michael H Bloch. (2023) Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis. The Lancet Child & Adolescent Health 7:2, pages 112-126.
Crossref
Peter Weber. 2023. Transition bei neurologischen Erkrankungen. Transition bei neurologischen Erkrankungen 179 191 .
Mesut Sarı, Güler Göl Özcan, Yasemin Akkuş İmrek, Yusuf Öztürk & Ali Evren Tufan. (2022) Atomoxetine Induced Tics in ADHD Treatment: A Case Report. Turkish Journal of Child and Adolescent Mental Health 29:1, pages 47-49.
Crossref
Veit Roessner, Heike Eichele, Jeremy S. Stern, Liselotte Skov, Renata Rizzo, Nanette Mol Debes, Péter Nagy, Andrea E. Cavanna, Cristiano Termine, Christos Ganos, Alexander Münchau, Natalia Szejko, Danielle Cath, Kirsten R. Müller-Vahl, Cara Verdellen, Andreas Hartmann, Aribert Rothenberger, Pieter J. Hoekstra & Kerstin J. Plessen. (2021) European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment. European Child & Adolescent Psychiatry 31:3, pages 425-441.
Crossref
Muneeba Rizwan, Noor ul ain Shahid, Noreen Naguit, Rakesh Jakkoju, Sadia Laeeq, Tiba Reghefaoui, Hafsa Zahoor, Ji Hyun Yook & Lubna Mohammed. (2022) Efficacy of Behavioural Intervention, Antipsychotics, and Alpha Agonists in the Treatment of Tics Disorder in Tourette’s Syndrome. Cureus.
Crossref
Alexey A. Tomskiy, Anna A. Poddubskaya, Anna A. Gamaleya & Oleg S. Zaitsev. 2022. Neurosurgical Management of Psychiatric Disorders, Part B. Neurosurgical Management of Psychiatric Disorders, Part B 41 72 .
Nicholas Cothros & Davide Martino. 2022. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics: Part A. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics: Part A 161 207 .
Nicholas Cothros & Tamara Pringsheim. 2022. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B 251 266 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.